• news.cision.com/
  • Bittium Oyj/
  • Invitation to a Press Conference on Bittium Corporation’s Half-Year Financial Report January-June 2022

Invitation to a Press Conference on Bittium Corporation’s Half-Year Financial Report January-June 2022

Report this content

Press Release

Free for publication on July 28, 2022, at 10.00 am (CEST+1)

Invitation to a Press Conference on Bittium Corporation’s Half-Year Financial Report January-June 2022

Bittium Corporation’s Half-Year Financial Report January-June 2022 will be published on Friday, August 5, 2022, at 8.00 am (CEST+1). The release will be available on company’s website www.bittium.com immediately after the publication.

Bittium will hold a webcast for media, analysts and institutional investors on Friday, August 5, 2022, at 9.00 am (CEST+1). The webcast will be held in Finnish. Bittium will also hold a webcast for media, analysts, and institutional investors in English on the same day at 11.00 am (CEST+1).

Link to the Finnish webcast: https://bittium.videosync.fi/2022-puolivuosikatsaus

Link to the English webcast: https://bittium.videosync.fi/2022-h1-results

A recording of the webcast and the presentation will be available after the conference on Bittium’s website at www.bittium.com/investors.

Further information:

Karoliina Malmi
Vice President, Corporate Communications and Marketing
Tel. +358 40 344 2789

Distribution:

Main media
www.bittium.com/investors

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its over 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Net sales in 2021 were EUR 86.9 million and operating profit was EUR 3.2 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com